Position in ALKS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$126,953,821
+$70,993,821 QoQ
Shares Held
3,590,323
+79.5% QoQ
Ownership
2.15%
of shares outstanding
% of Portfolio
2.62%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Deep Track Capital, LP holds $173,093,821 across 2 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (73.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
3,590,323 | $126,953,821 | |
| 2 | ANIP |
Ani Pharmaceuticals Inc
|
600,000 | $46,140,000 |
All Filings in ALKS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $126,953,821 | 3,590,323 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $55,960,000 | 2,000,000 | Shares | Sole | 2026-02-13 | |
| 2024-09-30 | $97,965,000 | 3,500,000 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $84,350,000 | 3,500,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $94,745,000 | 3,500,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $110,960,000 | 4,000,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $106,438,000 | 3,800,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $93,900,000 | 3,000,000 | Shares | Sole | 2023-09-06 | |
| 2023-03-31 | $84,570,000 | 3,000,000 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||